Literature DB >> 16053665

Tissue eosinophilic infiltration: a useful marker for assessing stromal invasion, survival and locoregional recurrence in head and neck squamous neoplasia.

Sadir J Alrawi1, Dongfeng Tan, Daniel L Stoler, Merril Dayton, Garth R Anderson, Pablo Mojica, Wade Douglas, Wesley Hicks, Nester Rigual, Thom Loree.   

Abstract

UNLABELLED: The assessment of stromal invasion in aerodigestive neoplastic squamous proliferation often poses diagnostic and therapeutic challenges. Eosinophilic infiltration is thought to be an adjunctive histologic criterion in determining tumor aggressiveness and invasion. We investigated whether an eosinophilic infiltration in head and neck squamous cell carcinoma measured in biopsies would aid in predicting tumor invasion, response to treatment, locoregional recurrence, and survival.
METHODS: Eighty-seven patients with in situ and invasive squamous cell carcinoma of the head and neck region were evaluated and treated according to their staging. The number of eosinophils per high-power field (eosinophil/HPF), and per 10 high-power fields (eosinophil/10 HPF) at the tumor interface and in tumor tissue, was counted and classified as focally or diffusely present. Each sample was assigned an eosinophilic index of 1-4 based on the number of eosinophils/HPF or 10 HPF. Of 87 patients, 20 patients were followed up after appropriate treatment for locoregional recurrence, distant metastasis, and disease-free survival.
RESULTS: Eosinophilic counts were elevated focally and/or diffusely more frequently in invasive squamous cell carcinoma than in noninvasive tumors. The increased eosinophilic counts, specifically > 10/HPF and > 20/10 HPF, were both significantly associated with stromal invasion. Greater than 10 eosinophils/HPF and/or > 20 eosinophils/10 HPF had the highest predictive power for invasion, with sensitivity, specificity, and positive predictive values of 66%, 94%, 96% and 61%, 100%, and 100%, respectively. Eosinophilic counts greater than 20 eosinophils/10 HPF and eosinophilic indices > 2 were virtually diagnostic for tumor invasion. Patients' biopsies with eosinophilic indices < 2 had a better survival (P = 0.0156). Using Cox regression analysis, we found that most patients' biopsies that had eosinophilic indices > 2 recurred locally or regionally.
CONCLUSIONS: The elevated eosinophilic counts in biopsies and eosinophilic indices in specimens of squamous cell carcinoma of the aerodigestive tract are a histopathologic marker associated with tumor invasion and a clinical predictor for aggressive tumor biology. Similarly, the presence of eosinophils meeting these thresholds in an excisional specimen should indicate the need for additional therapeutic measures and close surveillance to detect earlier locoregional recurrence and possible distant metastasis.

Entities:  

Mesh:

Year:  2005        PMID: 16053665     DOI: 10.1097/00130404-200505000-00008

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  17 in total

1.  Eosinophils may predict occult lymph node metastasis in early oral cancer.

Authors:  D T Oliveira; T P Biassi; S E S Faustino; A L Carvalho; G Landman; L P Kowalski
Journal:  Clin Oral Investig       Date:  2011-12-14       Impact factor: 3.573

2.  Pancreatobiliary Maljunction-associated Gallbladder Cancer Is as Common in the West, Shows Distinct Clinicopathologic Characteristics and Offers an Invaluable Model for Anatomy-induced Reflux-associated Physio-chemical Carcinogenesis.

Authors:  Takashi Muraki; Burcin Pehlivanoglu; Bahar Memis; Michelle D Reid; Takeshi Uehara; Olca Basturk; Jennifer Golia Pernicka; David S Klimstra; William R Jarnagin; Tetsuya Ito; Osamu Hasebe; Shinji Okaniwa; Naoto Horigome; Takeshi Hisa; Pardeep Mittal; Juan M Sarmiento; Shishir K Maithel; Jill Koshiol; Susan Tsai; Douglas Evans; Mert Erkan; Volkan Adsay
Journal:  Ann Surg       Date:  2020-11-12       Impact factor: 13.787

3.  Quantitative Evaluation of Tumour--Associated Tissue Eosinophilia and Cyclo-oxegenase-2 Gene in Oral Cancer Patients with Assessment of Long Term Outcomes.

Authors:  N Rakesh; Asha Iyengar; Kuhu Majumdar; G S Vidya; S S Shantha Kumar
Journal:  Pathol Oncol Res       Date:  2015-11-17       Impact factor: 3.201

Review 4.  Tumor associated tissue eosinophilia in oral squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Nilookumari Choudhary; Gargi S Sarode; Monal Yuwanati; Nikunj Maniyar; Sachin C Sarode; Amol R Gadbail; Shailesh Gondivkar; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2020-11-23

5.  Pretreatment Eosinophil Counts in Patients With Advanced or Metastatic Urothelial Carcinoma Treated With Anti-PD-1/PD-L1 Checkpoint Inhibitors.

Authors:  Jose Mauricio Mota; Min Yuen Teo; Karissa Whiting; Han A Li; Ashely M Regazzi; Chung-Han Lee; Samuel A Funt; Dean Bajorin; Irina Ostrovnaya; Gopa Iyer; Jonathan E Rosenberg
Journal:  J Immunother       Date:  2021-09-01       Impact factor: 4.912

6.  Tumour associated tissue eosinophilia as a predictor of locoregional recurrence in oral squamous cell carcinoma.

Authors:  Nagaraju Rakesh; Yashoda Devi; Kuhu Majumdar; Sujatha S Reddy; Kunal Agarwal
Journal:  J Clin Exp Dent       Date:  2015-02-01

7.  Eosinophils and oral squamous cell carcinoma: a short review.

Authors:  C P Martinelli-Kläy; B R R N Mendis; T Lombardi
Journal:  J Oncol       Date:  2009-12-16       Impact factor: 4.375

8.  Eosinophils in human oral squamous carcinoma; role of prostaglandin D2.

Authors:  Francis Davoine; Adrian Sim; Charlie Tang; Sibina Fisher; Caroline Ethier; Lakshmi Puttagunta; Yingqi Wu; W Tim McGaw; Donald Yu; Lisa Cameron; Darryl J Adamko; Redwan Moqbel
Journal:  J Inflamm (Lond)       Date:  2013-01-31       Impact factor: 4.981

9.  Myeloid cells: Prime drivers of tumor progression.

Authors:  Benjamin Toh; Benjamin Toh; Jean-Pierre Abastado; Jean-Pierre Abastado
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

10.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.